Bangalore: India Chambers USA has appointed Dr Anand Swaroop, co-founder of NutrifyToday, as Country Representative (USA) and Head of the newly launched India Chambers USA Desk in Somerset, New Jersey. The initiative is aimed at creating a high-velocity corridor between India and the United States in responsible nutrition, moving beyond raw material exports to science-driven, outcome-based preventive health solutions.
The Desk, housed at NutrifyToday’s Somerset office, will serve as an open platform for industry leaders from both countries to meet, negotiate partnerships and run joint technical programs. It is designed as a transaction-focused hub, hosting C-suite roundtables, regulatory alignment workshops, and R&D collaborations.
According to NutrifyToday, the Desk will prioritize practical, time-bound initiatives such as linking U.S. brand R&D teams with Indian clinical sites, launching a digital dashboard for India’s certified organic acreage, aligning Indian suppliers with U.S. quality standards, co-funding bi-national innovations, and creating a startup exchange between incubators on both shores. It will also work on standardizing Ayurveda-based polyherbal formulations using advanced methods like fingerprinting, DNA barcoding and metabolomics, while offering compliance support to first-time exporters.
Industry dynamics make this the right moment, with brands demanding reliable supplies, evidence-backed formulations and faster regulatory navigation. India brings biodiversity and cost-effective science, while the U.S. contributes scale, validation and stringent quality benchmarks. A permanent Desk in New Jersey will help reduce friction, enabling faster movement from discussions to pilots and market launches.
Ayurveda remains India’s key differentiator, but the focus is shifting to testable outcomes. The Desk will support joint clinical studies and real-world evidence designs for classic actives such as ashwagandha, turmeric, boswellia and bacopa, while also encouraging frontier work on AI-enabled phytopharma and biotech-based innovations.
Over the next 12 to 24 months, the first set of milestones will include MoUs between Indian suppliers and U.S. brands with joint evidence plans, a bi-national startup cohort, a Phase I public dashboard on organic land banks, release of polyherbal standardization toolkits, and regulatory navigation clinics at the Somerset office.
Dr Swaroop noted that with AI, biotechnology and deeper clinical research, the supplements category can transform into a measurable preventive health industry built around outcomes such as glycaemic control, sleep quality and stress markers. The India Chambers USA Desk, operating on an open-door model, signals a new phase where India and the U.S. will co-develop and scale responsible nutrition with shared standards and shared value.
